Cases & Deals

  • Home
  • Practices
  • Celgene develops global patent portfolio for small molecule therapeutics

Share

Celgene develops global patent portfolio for small molecule therapeutics

December 2010

Client(s) Celgene Corporation, a Bristol-Myers Squibb company

Jones Day represents Celgene Corporation (now a Bristol-Myers Squibb company) in the establishment of a global patent portfolio related to small molecules for the treatment of cancer and autoimmune disorders.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.